within Pharmacolibrary.Drugs.ATC.C;

model C07AB10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.2,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0033333333333333335,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Epanolol is a cardioselective beta-1 adrenergic receptor blocker (beta-blocker) that was developed for the treatment of hypertension and angina pectoris. It is not widely used today and does not have current approval in major markets; it is mostly of historical or investigational interest.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical healthy adult population; no referenced publication with primary pharmacokinetic data found.</p><h4>References</h4><ol><li><p>Hosie, J, et al., &amp; Cockshott, ID (1990). Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris. <i>British journal of clinical pharmacology</i> 29(3) 333–337. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1990.tb03644.x&quot;>10.1111/j.1365-2125.1990.tb03644.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1968755/&quot;>https://pubmed.ncbi.nlm.nih.gov/1968755</a></p></li><li><p>Laher, MS, et al., &amp; Cockshott, ID (1990). ICI 141,292 (epanolol)--pharmacokinetics after single and repeated oral administration in the elderly with moderate renal impairment. <i>European journal of clinical pharmacology</i> 39(1) 71–74. DOI:<a href=&quot;https://doi.org/10.1007/BF02657061&quot;>10.1007/BF02657061</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1980462/&quot;>https://pubmed.ncbi.nlm.nih.gov/1980462</a></p></li><li><p>Cockshott, ID (1989). Pharmacokinetics of epanolol (ICI 141,292) in healthy young volunteers and comparative data in elderly patients with angina and subjects with renal or hepatic impairment. <i>Drugs</i> 38 Suppl 2 10–17. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198900382-00005&quot;>10.2165/00003495-198900382-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2575975/&quot;>https://pubmed.ncbi.nlm.nih.gov/2575975</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07AB10;
